Naltrexone Hydrochloride
Who holds supplier records for Naltrexone Hydrochloride? 12 organisations hold a current record for Naltrexone Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), United States (2), Slovakia (1) and Netherlands (1); not recorded for 6.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Naltrexone Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/naltrexone-hydrochloride
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Naltrexone Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21217, 36560 · latest filing Mar 2022
- MACFARLAN SMITH LTDCEP Company GMP cert on recordActive DMF 21590 · latest filing Apr 2008
- NORAMCO INCUnited StatesCEPActive DMF 23325 · latest filing Dec 2009
- SANECA PHARMACEUTICALS ASSlovakiaCEP Company GMP cert on recordActive DMF 41264 · latest filing Jun 2025
- SIEGFRIED LTDCEPActive DMF 23214 · latest filing Oct 2009
- SPECGX LLCUnited StatesCEPActive DMF 6265 · latest filing Apr 1986
- ASPEN OSS BVNetherlands Company GMP cert on recordActive DMF 15102 · latest filing Oct 2000
- FRANCOPIA A EUROAPI COActive DMF 20623 · latest filing Jun 2007
- STHREE CHEMICALS PRIVATE LTDActive DMF 42434 · latest filing Sept 2025
- FRANCOPIACEP
- IndiaCEP Company GMP cert on record
- SALARS SPACEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Naltrexone Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| RUSAN PHARMA LIMITED Mumbai | IN | CEP 2016-053 - Rev 01 Naltrexone hydrochloride | Jun 2026 | — |
| FRANCOPIA Paris | FR | CEP 2009-287 - Rev 04 Naltrexone hydrochloride | Oct 2025 | — |
| SANECA PHARMACEUTICALS A.S. Hlohovec | SK | CEP 2025-194 - Rev 00 Naltrexone hydrochloride, Process 2 | Jun 2025 | Inspected Jun 2026 Slovakia |
| SPECGX LLC Webster Groves | US | CEP 2018-218 - Rev 02 Naltrexone hydrochloride | Nov 2024 | — |
| NORAMCO, LLC. Wilmington | US | CEP 2020-291 - Rev 02 Naltrexone hydrochloride, Wavelength site | Apr 2024 | — |
| SIEGFRIED LTD. Zofingen | CH | R1-CEP 2009-352 - Rev 03 Naltrexone hydrochloride | Feb 2023 | — |
| S.A.L.A.R.S. S.p.A. Como | IT | R1-CEP 2006-117 - Rev 02 Naltrexone hydrochloride | May 2017 | — |
| MACFARLAN SMITH LIMITED Edinburgh | GB | R1-CEP 2008-058 - Rev 00 Naltrexone hydrochloride | Sept 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Naltrexone Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201149).
Chemical identity
- IUPAC name
- (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride
- Canonical SMILES
- [H+].C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O.[Cl-]
- InChIKey
- RHBRMCOKKKZVRY-ITLPAZOVSA-N
- Synonyms
- Adepend, Depade, EN-1639A, EN-1639A (AS HYDROCHLORIDE), Nalorex, Naltrexone hcl, Naltrexone hydrochloride, Naltrexone hydrochloride component of contrave, Naltrexone hydrochloride component of embeda, Naltrexone hydrochloride component of troxyca, Opizone, Revia
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Opioid Antagonist
- Mechanism of action
- Opioid Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Naltrexone Hydrochloride?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Naltrexone Hydrochloride: Sun Pharmaceutical Industries Limited (India), MACFARLAN SMITH LTD, NORAMCO INC (United States), SANECA PHARMACEUTICALS AS (Slovakia), SIEGFRIED LTD, SPECGX LLC (United States), ASPEN OSS BV (Netherlands) and FRANCOPIA A EUROAPI CO, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Naltrexone Hydrochloride Drug Master Files are active?
Sun Pharmaceutical Industries Limited (DMF 21217, 36560), MACFARLAN SMITH LTD (DMF 21590), NORAMCO INC (DMF 23325), SANECA PHARMACEUTICALS AS (DMF 41264), SIEGFRIED LTD (DMF 23214), SPECGX LLC (DMF 6265), ASPEN OSS BV (DMF 15102) and FRANCOPIA A EUROAPI CO (DMF 20623) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Naltrexone Hydrochloride have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Naltrexone Hydrochloride on the EDQM register, including RUSAN PHARMA LIMITED Mumbai (IN), FRANCOPIA Paris (FR), SANECA PHARMACEUTICALS A.S. Hlohovec (SK), SPECGX LLC Webster Groves (US), NORAMCO, LLC. Wilmington (US) and SIEGFRIED LTD. Zofingen (CH) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Naltrexone Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Naltrexone Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.